Citation Impact
Citing Papers
X-linked cholestasis in mouse due to mutations of the P4-ATPase ATP11C
2011 StandoutNobel
EGFR Mutations in Lung Cancer: Correlation with Clinical Response to Gefitinib Therapy
2004 StandoutScience
Expression of human MRP6, a homologue of the multidrug resistance protein gene MRP1, in tissues and cancer cells.
1999
Transport of amphipathic anions by human multidrug resistance protein 3.
2000
Expression of multidrug resistance protein-related genes in lung cancer: correlation with drug response.
1999
The ABC transporter Bcrp1/ABCG2 is expressed in a wide variety of stem cells and is a molecular determinant of the side-population phenotype
2001 Standout
A Family of Drug Transporters: the Multidrug Resistance-Associated Proteins
2000
Increased Bioavailability of the Food-Derived Carcinogen 2-Amino-1-methyl-6-phenylimidazo[4,5-b]pyridine in MRP2-Deficient Rats
2001
Sensitivity to gefitinib (Iressa, ZD1839) in non-small cell lung cancer cell lines correlates with dependence on the epidermal growth factor (EGF) receptor/extracellular signal-regulated kinase 1/2 and EGF receptor/Akt pathway for proliferation
2004
ATP-Dependent Efflux of CPT-11 and SN-38 by the Multidrug Resistance Protein (MRP) and Its Inhibition by PAK-104P
1999
Multidrug resistance in cancer: role of ATP–dependent transporters
2002 Standout
Expression of the multidrug resistance proteins MRP2 and MRP3 in human hepatocellular carcinoma
2001
MRP3, an organic anion transporter able to transport anti-cancer drugs
1999
Pseudoxanthoma elasticum: Mutations in the MRP6 gene encoding a transmembrane ATP-binding cassette (ABC) transporter
2000
Active Efflux of CPT-11 and Its Metabolites in Human KB-Derived Cell Lines
1999
Comparison of the Functional Characteristics of the Nucleotide Binding Domains of Multidrug Resistance Protein 1
2000
Extracellular matrix binding mixed micelles for drug delivery applications
2009 StandoutNobel
Role of transport proteins in drug absorption, distribution and excretion
2001
The role of copper transporters in the development of resistance to Pt drugs
2004
Reversal of resistance by GF120918 in cell lines expressing the ABC half-transporter, MXR
1999
Y-box factor YB1 controls p53 apoptotic function
2005
Conjugate export pumps of the multidrug resistance protein (MRP) family: localization, substrate specificity, and MRP2-mediated drug resistance
1999
Epidermal growth factor receptor mutations in lung cancer
2007 Standout
Principles of nanoparticle design for overcoming biological barriers to drug delivery
2015 Standout
Cancer drug resistance: an evolving paradigm
2013 Standout
The resurgence of platinum-based cancer chemotherapy
2007 Standout
TiO2 Nanotubes: Synthesis and Applications
2011 Standout
Cetuximab Monotherapy and Cetuximab plus Irinotecan in Irinotecan-Refractory Metastatic Colorectal Cancer
2004 Standout
Coordinated Transcription of Key Pathways in the Mouse by the Circadian Clock
2002 Standout
Identification of two Y-Box binding proteins that interact with the promoters of columbid annexin I genes
1998
Molecular mechanisms of cisplatin resistance
2011 Standout
Exploiting tumour hypoxia in cancer treatment
2004 Standout
Reprogramming of vascular smooth muscle α-actin gene expression as an early indicator of dysfunctional remodeling following heart transplant
2002
Blinded by the Light: The Growing Complexity of p53
2009 Standout
Targeting multidrug resistance in cancer
2006 Standout
A myocardial lineage derives from Tbx18 epicardial cells
2008 StandoutNature
Some p53-binding proteins that can function as arbiters of life and death
2006
Role of Oxidative Modifications in Atherosclerosis
2004 Standout
Cellular processing of platinum anticancer drugs
2005 Standout
Irinotecan: mechanisms of tumor resistance and novel strategies for modulating its activity
2002
Effect of Multidrug Resistance-Reversing Agents on Transporting Activity of Human Canalicular Multispecific Organic Anion Transporter
1999
Polyphenols: food sources and bioavailability
2004 Standout
Selection with melphalan or paclitaxel (Taxol) yields variants with different patterns of multidrug resistance, integrin expression and in vitro invasiveness
2001
Silver nanoparticles: Green synthesis and their antimicrobial activities
2008 Standout
p53 in health and disease
2007 Standout
Self-assembly of block copolymers
2012 Standout
Analysis of comptothecin resistance in yeast: relevance to cancer therapy
1998
The Human ATP-Binding Cassette (ABC) Transporter Superfamily
2001
Pluronic® block copolymers as novel polymer therapeutics for drug and gene delivery
2002
Transcriptional regulation of ABC drug transporters
2003
Differential Specificities and Simultaneous Occupancy of Human MutSα Nucleotide Binding Sites
2004 StandoutNobel
Tumor metastasis: mechanistic insights and clinical challenges
2006 Standout
Relevance of Multidrug Resistance Proteins for Intestinal Drug Absorption in vitro and in vivo
2002
Pluronic® block copolymers for overcoming drug resistance in cancer
2002
MOAT-E (ARA) is a full-length MRP/cMOAT subfamily transporter expressed in kidney and liver
1999
Mutations in the ABC 1 gene in familial HDL deficiency with defective cholesterol efflux
1999
Recent insights into platinum drug resistance in cancer
1998
Topoisomerase I inhibitors: camptothecins and beyond
2006 Standout
Clinical Perspectives on Platinum Resistance
2000
Stem cell-derived polarized hepatocytes
2020 StandoutNobel
Hepatobiliary transport
2000
Hypoxia-inducible factors: mediators of cancer progression and targets for cancer therapy
2012 StandoutNobel
Spermidine/Spermine N1-Acetyltransferase-1 Binds to Hypoxia-inducible Factor-1α (HIF-1α) and RACK1 and Promotes Ubiquitination and Degradation of HIF-1α
2007 StandoutNobel
The Next Generation of Platinum Drugs: Targeted Pt(II) Agents, Nanoparticle Delivery, and Pt(IV) Prodrugs
2016 Standout
Biochemical Modulation of Cisplatin Mechanisms of Action: Enhancement of Antitumor Activity and Circumvention of Drug Resistance
2003 Standout
Review of titania nanotubes synthesized via the hydrothermal treatment: Fabrication, modification, and application
2007
Low‐Cost Higher Loading of a Sulfur Cathode
2015 StandoutNobel
Mammalian drug efflux transporters of the ATP binding cassette (ABC) family: an overview
2012 Standout
Tumour stem cells and drug resistance
2005 Standout
Evolutionary conservation predicts function of variants of the human organic cation transporter, OCT1
2003
Hypoxia-inducible factor-1-dependent regulation of the multidrug resistance (MDR1) gene.
2002
Antitumor Antibiotics: Bleomycin, Enediynes, and Mitomycin
2005 Standout
The Role of Cellular Accumulation in Determining Sensitivity to Platinum-Based Chemotherapy
2007
The Enzymes, Regulation, and Genetics of Bile Acid Synthesis
2003 Standout
Degradable Controlled-Release Polymers and Polymeric Nanoparticles: Mechanisms of Controlling Drug Release
2016 Standout
DAF-16 Target Genes That Control C. elegans Life-Span and Metabolism
2003 StandoutScienceNobel
Functional Nanomaterials for Phototherapies of Cancer
2014 Standout
Nanotechnology for Multimodal Synergistic Cancer Therapy
2017 Standout
The development of anticancer ruthenium(ii ) complexes: from single molecule compounds to nanomaterials
2017 Standout
Mammalian ABC Transporters in Health and Disease
2002
cis -Diammine(pyridine)chloroplatinum(II), a monofunctional platinum(II) antitumor agent: Uptake, structure, function, and prospects
2008 StandoutNobel
Enhanced photochromism of Ag loaded self-organized TiO2 nanotube layers
2007
Aggregation Behavior of Poly(ethylene glycol-bl-propylene sulfide) Di- and Triblock Copolymers in Aqueous Solution
2009 StandoutNobel
Annexins: From Structure to Function
2002 Standout
Structure of P-Glycoprotein Reveals a Molecular Basis for Poly-Specific Drug Binding
2009 StandoutScience
Aerobic Oxidation of Alcohols over Gold Catalysts: Role of Acid and Base
2008
Advances in Copper Complexes as Anticancer Agents
2013 Standout
Capillary Absorption of Metal Nanodroplets by Single-Wall Carbon Nanotubes
2008
Gold-Catalyzed Carbon−Heteroatom Bond-Forming Reactions
2011 Standout
A phase I trial of doxorubicin, paclitaxel, and valspodar (PSC 833), a modulator of multidrug resistance.
2001
Circadian control of XPA and excision repair of cisplatin-DNA damage by cryptochrome and HERC2 ubiquitin ligase
2010 StandoutNobel
Oxygen-dependent regulation of mitochondrial respiration by hypoxia-inducible factor 1
2007 StandoutNobel
Multidrug-resistance protein 5 is a multispecific organic anion transporter able to transport nucleotide analogs
2000
Specific detection of multidrug resistance proteins MRP1, MRP2, MRP3, MRP5, and MDR3 P-glycoprotein with a panel of monoclonal antibodies.
2000
Works of S. Toh being referenced
Multidrug resistance-associated protein subfamily transporters and drug resistance.
1999
A canalicular multispecific organic anion transporter (cMOAT) antisense cDNA enhances drug sensitivity in human hepatic cancer cells.
1997
Genomic Structure of the Canalicular Multispecific Organic Anion–Transporter Gene (MRP2/cMOAT) and Mutations in the ATP-Binding–Cassette Region in Dubin-Johnson Syndrome
1999
Isolation of a Novel Human Canalicular Multispecific Organic Anion Transporter, cMOAT2/MRP3, and Its Expression in Cisplatin-Resistant Cancer Cells with Decreased ATP-Dependent Drug Transport
1998
The human multidrug resistance protein 2 gene: Functional characterization of the 5′-flanking region and expression in hepatic cells
1999
Genomic organization of the human Y-box protein (YB-1) gene
1998
Nuclear translocation of the Y‐box binding protein by ultraviolet irradiation
1997
Synthesis and characterization of metal-filled carbon nanotubes by microwave plasma chemical vapor deposition
2005
Fabrication and photochromic study of titanate nanotubes loaded with silver nanoparticles
2006